Floatz logo

Phentolamine

Vasoconstriction

University of Missouri-ColumbiaSmall moleculeEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Vasoconstriction cohort.

Asset / SponsorPhaseRating
M-SYMPATHOL
University of Missouri-Columbia
Early Phase 1C
Noradrenaline
University of Missouri-Columbia
Early Phase 1C
Bxcl501
University of Missouri-Columbia
Early Phase 1C

Same molecule, other indications

Phentolamine is also rated in:

prostate cancerDormant
CCC
Indicative ·
48 / 100
View asset →
obesity disorderDormant
CC
Indicative ·
41 / 100
View asset →
VasodilationDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →